Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd. is a Chinese pharmaceutical joint venture established in Jiangsu province, focused on the development, production, and commercialization of small molecule drugs and herbal medicines. The company was the first globally to develop leflunomide tablets for rheumatoid arthritis—approved in China since the late '90s—and has expanded into other therapeutic areas including immunology, nephrology, hematology, endocrinology/metabolic disease, infectious diseases, and immune system disorders. It maintains an integrated value chain from R&D through manufacturing to marketing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd..